MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers

Por Merhautova, Jana, Demlova, Regina, Slaby, Ondrej
Publicado no Front Pharmacol (2016)

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

Por Slaby, Ondrej, Svoboda, Marek, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2009

Novel classes of non-coding RNAs and cancer

Por Sana, Jiri, Faltejskova, Petra, Svoboda, Marek, Slaby, Ondrej
Publicado em 2012

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer

Por Slaby, Ondrej, Bienertova-Vasku, Julie, Svoboda, Marek, Vyzula, Rostislav
Publicado em 2012

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications

Por Sana, Jiri, Hajduch, Marian, Michalek, Jaroslav, Vyzula, Rostislav, Slaby, Ondrej
Publicado no J Cell Mol Med (2011)

MicroRNA-206: a Promising Theranostic Marker

Por Novák, Jan, Kružliak, Peter, Bienertová-Vašků, Julie, Slabý, Ondřej, Novák, Miroslav
Publicado em 2014

MicroRNA Profiling of Activated and Tolerogenic Human Dendritic Cells

Por Stumpfova, Zuzana, Hezova, Renata, Meli, Albano Carlo, Slaby, Ondrej, Michalek, Jaroslav
Publicado em 2014

MicroRNAs Involvement in Radioresistance of Head and Neck Cancer

Por Ahmad, Parwez, Sana, Jiri, Slavik, Marek, Slampa, Pavel, Smilek, Pavel, Slaby, Ondrej
Publicado no Dis Markers (2017)

Polymorphism in miR-31 and miR-584 binding site in the angiotensinogen gene differentially influences body fat distribution in both sexes

Por Machal, Jan, Novak, Jan, Hezova, Renata, Zlamal, Filip, Vasku, Anna, Slaby, Ondrej, Bienertova-Vasku, Julie
Publicado no Genes Nutr (2015)

Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer

Por Thorenoor, Nithyananda, Faltejskova-Vychytilova, Petra, Hombach, Sonja, Mlcochova, Jitka, Kretz, Markus, Svoboda, Marek, Slaby, Ondrej
Publicado no Oncotarget (2015)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

Por Svoboda Marek, Sana Jiri, Redova Martina, Navratil Jiri, Palacova Marketa, Fabian Pavel, Slaby Ondrej, Vyzula Rostislav
Publicado em 2012-03-01

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

Por Svoboda, Marek, Sana, Jiri, Redova, Martina, Navratil, Jiri, Palacova, Marketa, Fabian, Pavel, Slaby, Ondrej, Vyzula, Rostislav
Publicado em 2012

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy

Por Nemecek, Radim, Berkovcova, Jitka, Radova, Lenka, Kazda, Tomas, Mlcochova, Jitka, Vychytilova-Faltejskova, Petra, Slaby, Ondrej, Svoboda, Marek
Publicado no Onco Targets Ther (2016)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Por Slaby, Ondrej, Jancovicova, Jana, Lakomy, Radek, Svoboda, Marek, Poprach, Alexandr, Fabian, Pavel, Kren, Leos, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2010

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Por Slaby, Ondrej, Jancovicova, Jana, Lakomy, Radek, Svoboda, Marek, Poprach, Alexandr, Fabian, Pavel, Kren, Leos, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2010

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Por Redova, Martina, Poprach, Alexandr, Nekvindova, Jana, Iliev, Robert, Radova, Lenka, Lakomy, Radek, Svoboda, Marek, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

Por Svoboda, Marek, Sana, Jiri, Fabian, Pavel, Kocakova, Ilona, Gombosova, Jana, Nekvindova, Jana, Radova, Lenka, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

Por GRELL, PETER, FABIAN, PAVEL, KHOYLOU, MARTA, RADOVA, LENKA, SLABY, ONDREJ, HRSTKA, ROMAN, VYZULA, ROSTISLAV, HAJDUCH, MARIAN, SVOBODA, MAREK
Publicado em 2012

MR-06 MicroRNA SIGNATURE ASSOCIATED WITH POOR OUTCOME OF GLIOBLASTOMA PATIENTS

Por Smrcka, Martin, Sana, Jiri, Lakomy, Radek, Fadrus, Pavel, Slampa, Pavel, Kren, Leos, Svoboda, Marek, Hajduch, Marian, Slaby, Ondrej
Publicado em 2014

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib

Por Merhautova, Jana, Hezova, Renata, Poprach, Alexandr, Kovarikova, Alena, Radova, Lenka, Svoboda, Marek, Vyzula, Rostislav, Demlova, Regina, Slaby, Ondrej
Publicado no Biomed Res Int (2015)